FLT4 and prostate carcinoma: Opposite to their long-known role in prostate cancer [85], the sex hormones have only recently received increased attention for the treatment of other diseases such as lymphedema, which can result from disturbances in the VEGF-C/VEGFR-3 signaling pathway [105].